Metabolic Research Peptides
GLP-2TZ
$75.00$75.00
● In stock
GLP-2TZ (LY3298176) is a synthetic 39-amino-acid peptide and dual agonist at the GIP and GLP-1 receptors (CAS 2023788-19-2, MW ~4813.45). Supplied as a ≥99% HPLC-tested lyophilized powder — with a lot-specific third-party COA available before purchase — for in-vitro and laboratory research applications only. Research Use Only — not for human or veterinary use.
Size
10mg
15mg
30mg
60mg
Compound Name
GLP-2TZ
Synonyms
Tirz; LY3298176; LY-3298176; GLP-2 TZ; GIP/GLP-1 RA
CAS Number
2023788-19-2
Molecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight
~4813.45 g/mol
Peptide Length
39 amino acids (synthetic)
Structure
GIP-based sequence; C20 fatty-diacid moiety via γ-glutamic-acid linker at Lys20; Aib residues; C-terminal amide
Receptor Targets
GIPR, GLP-1R (dual agonist)
Compound Class
Synthetic dual incretin (GIP/GLP-1) receptor agonist peptide
Purity
≥99% (HPLC) — see lot COA
Identity
Confirmed by LC-MS (per lot COA)
Appearance
White lyophilized powder
Solubility
Soluble in water / aqueous buffer
Available Sizes
0mg, 15mg, 30mg, 60mg
Storage (lyophilized)
-20°C, sealed, dark, dry
Storage (reconstituted)
2–8°C short-term; aliquot & freeze -20°C; avoid freeze-thaw
Synthesis
Solid-phase peptide synthesis (SPPS)
Testing Lab
Freedom Diagnostics
Test Methods
Purity by HPLC; identity by LC-MS
Shipped From
USA
Certificate of Analysis
Lot-specific COA available
For laboratory research use only. Not for human or veterinary
consumption. This product should only be handled by qualified
professionals.
Product information
GLP-2TZ (LY3298176) is a synthetic 39-amino-acid peptide that acts as a dual agonist at two receptors: the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R). Its primary structure is based on the GIP sequence and incorporates non-coded residues (α-aminoisobutyric acid, Aib) and a C20 fatty-diacid moiety conjugated at the lysine-20 residue via a γ-glutamic-acid linker, contributing to its structural stability profile. This product is supplied as a lyophilized powder in multiple sizes, synthesized by solid-phase peptide synthesis (SPPS) and characterized by HPLC (purity) and LC-MS (identity), with a lot-specific third-party Certificate of Analysis available before purchase. It is intended exclusively for in-vitro laboratory research and analytical applications. In the research literature, GLP-2TZ is referenced as a reference dual-receptor agonist used as a tool compound in the study of GIPR and GLP-1R receptor pharmacology and signaling.